Atlas Trials

Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

Clinical trial NCT01300728 · COMPLETED

Trial details

NCT number
NCT01300728
Sponsor
Sutter Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2011-01-01
Primary completion
2020-03-12
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.